Finance logo
right-img
Home
Featured News
Finance News
Banking News
Home
| Bionomics to test BNC210 for PTSD
Bionomics to test BNC210 for PTSD
December 08, 2015
BIONOMICS will launch a phase 2 trial of BNC210 as a treatment for post traumatic stress disorder, following a US$12 million capital raising.
Read more at:
http://news.com.au.feedsportal.com/c/34564/f/632570/s/4c139a32/sc/28/l/0L0Snews0N0Bau0Cfinance0Cbusiness0Cbionomics0Eto0Etest0Ebnc210A0Efor0Eptsd0Cstory0Ee6frfkur0E12276382867750Dfrom0Fpublic0Irss/story01.htm
Other News
Where everyone gets $1100 every month
Unemployment tipped to rise a little
Endologix, Inc. (NASDAQ:ELGX) Receives Average Rating of “Buy” from Analysts
Synovus Financial Corp. (NYSE:SNV) Receives Consensus Recommendation of “Buy” from Analysts
Site Created by finaceandbankingnewsnow.com
